ID: ALA5273022

Max Phase: Preclinical

Molecular Formula: C20H18N2O3S

Molecular Weight: 366.44

Associated Items:

Representations

Canonical SMILES:  CS1(C2=CC(=O)C3=C(C2)c2nccc4cccc(c24)N3)CCC(=O)OC1

Standard InChI:  InChI=1S/C20H18N2O3S/c1-26(8-6-17(24)25-11-26)13-9-14-19(16(23)10-13)22-15-4-2-3-12-5-7-21-20(14)18(12)15/h2-5,7,10,22H,6,8-9,11H2,1H3

Standard InChI Key:  ARXWLSVXOGPTMO-UHFFFAOYSA-N

Associated Targets(non-human)

Mycobacterium 258 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 366.44Molecular Weight (Monoisotopic): 366.1038AlogP: 3.57#Rotatable Bonds: 1
Polar Surface Area: 68.29Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: -1.71CX Basic pKa: 7.92CX LogP: -3.27CX LogD: -2.20
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.78Np Likeness Score: 0.27

References

1. Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari VK..  (2017)  Drug development against tuberculosis: Impact of alkaloids.,  137  [PMID:28628823] [10.1016/j.ejmech.2017.06.005]

Source